½ÃÀ庸°í¼­
»óǰÄÚµå
1593036

¼¼°èÀÇ Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀå : Á¦Ç°º°, ÀûÀÀ Áúȯº° ¿¹Ãø(2025-2030³â)

Intravenous Infusion Pump Market by Product (Ambulatory Infusion Pumps, Enteral Infusion Pumps, Implantable Infusion Pumps), Disease Indication (Analgesia or Pain Management, Chemotherapy, Diabetes) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 188 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀåÀº 2023³â¿¡ 44¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 48¾ï 5,000¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 9.85%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 85¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ´Â ¿µ¾çÁ¦ ¹× ¾à¹°°ú °°Àº ¾×ü¸¦ Á¦¾î µÈ ¾çÀ¸·Î ȯÀÚÀÇ Ç÷·ù·Î Á÷Á¢ Àü´ÞÇϵµ·Ï ¼³°èµÈ Áß¿äÇÑ ÀÇ·á±â±âÀÔ´Ï´Ù. ±×¸®°í ȯÀÚÀÇ Àú·Å Àü¼ºÀ» È®º¸Çϱâ À§ÇØ, ƯÈ÷ ÁßÁõ ȯÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ ÀÇ·á ÇöÀå¿¡¼­´Â ¼ö¾×À» Á¤È®ÇÏ°Ô Åõ¿©ÇÒ Çʿ䰡 Àֱ⠶§¹®¿¡ ¹ß»ýÇϰí ÀÖ½À´Ï´Ù. ÃÖÁ¾ ¿ëµµÀÇ ¹üÀ§´Â Á¤È®ÇÑ ¼ö¾× °ü¸®°¡ Áß¿äÇÑ Á¾¾çÇÐ, ¼ÒÈ­±â º´ÇÐ, ¼Ò¾Æ°ú, ÅëÁõ °ü¸® µî ´Ù¾çÇÑ ÀÇ·á ¿µ¿ª¿¡ °ÉÃÄ ÀÖ½À´Ï´Ù. Áõ°¡, ÇコÄɾî ÀåºñÀÇ ±â¼ú Áøº¸´Â ÁÖÀÔ ÆßÇÁ ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¼ºÀå ¿äÀÎÀÔ´Ï´Ù. À̸¦ ÅëÇØ µ¥ÀÌÅÍ ºÐ¼®°ú ¿ø°Ý ¸ð´ÏÅ͸µ ±â´ÉÀ» °­È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª °í±Þ ÆßÇÁÀÇ °íºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ±â¼úÀû ¿ÀÀÛµ¿ÀÇ À§Çè µîÀÇ Á¦¾àÀÌ ½ÃÀå ¼ºÀå¿¡ Å« °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ Àåºñ¸¦ Á¶ÀÛÇϰí ȯÀÚÀÇ ¾ÈÀüÀ» º¸ÀåÇϱâ À§ÇØ ÈÆ·Ã¹ÞÀº ÀÇ·á Àü¹®°¡°¡ ÇÊ¿äÇÏ´Ù´Â °ÍÀº ½ÃÀå È®´ë¸¦ ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, °í±Þ ¾ÈÀü ±â´ÉÀ» °®Ãá ºñ¿ë È¿À²ÀûÀÎ ÁÖÀÔ ÆßÇÁ °³¹ß, ¹«¼± Åë½Å ±â´É Çâ»ó, ÈÞ¸Õ ¿À·ù¸¦ ÁÙÀ̱â À§ÇÑ »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º ¼³°è °­È­ µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â´ÉÀ» ¼Õ»ó½ÃŰÁö ¾Ê°í È޴뼺À» ³ôÀ̱â À§ÇÑ ÀåÄ¡ ¼ÒÇüÈ­ÀÇ Á¶»çµµ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ÇÁ·¹ÀÓ ¿öÅ©°¡ Ư¡ÀÔ´Ï´Ù. ÁøÈ­ÇÏ´Â ÇコÄɾî Ç¥Áذú ¼ö¿ä¿¡ ´ëÀÀÇϱâ À§Çؼ­´Â ²÷ÀÓ¾ø´Â ±â¼ú Çõ½ÅÀÌ ÇÊ¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 44¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 48¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 85¾ï 7,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 9.85%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ³ë³â Àα¸¿¡ µû¸¥ ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡
    • ¿Ü°ú ¼ö¼úÀ» ¹Þ´Â »ç¶÷ Áõ°¡
    • ¿Ü·¡¿ë ÁÖÀÔ ÆßÇÁ ¼ö¿ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÁÖÀÔ ÆßÇÁ¿¡ ´ëÇÑ È¯ÀÚÀÇ ¾ÈÀü À§Çè°ú Åõ¾à ½Ç¼ö
  • ½ÃÀå ±âȸ
    • Ư¼ö ÁÖÀÔ ÆßÇÁÀÇ Ã¤¿ë È®´ë
    • ÁÖÀÔ ÆßÇÁÀÇ ±â¼úÀû Áøº¸
  • ½ÃÀåÀÇ °úÁ¦
    • Àç»ý ÁÖÀÔ ÆßÇÁÀÇ Ã¤¿ë Áõ°¡

Porter's Five Forces : Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ½ÃÀåÀÇ ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í, º¥´õ´Â °æÀïÀÌ °ÝÈ­ÇÏ´Â °¡¿îµ¥ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» Çϱâ À§ÇØ ÇÊ¿äÇÕ´Ï´Ù. Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Á¤º¸¸¦ ±â¹ÝÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. 4°³ÀÇ »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇöÀå °­È­¸¦ ¸ñÇ¥·ÎÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • °í·ÉÈ­¿¡ µû¶ó ¸¸¼ºÁúȯÀÇ ¹ß»ý·üµµ Áõ°¡
      • ¿Ü°ú ¼ö¼úÀ» ¹Þ´Â »ç¶÷ÀÇ ¼ö Áõ°¡
      • ¿Ü·¡ ÁÖÀÔ ÆßÇÁ ¼ö¿ä Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ÁÖÀÔ ÆßÇÁÀÇ È¯ÀÚ ¾ÈÀü À§Çè°ú Åõ¾à ½Ç¼ö
    • ±âȸ
      • Ư¼ö ÁÖÀÔ ÆßÇÁÀÇ Ã¤¿ë Áõ°¡
      • ÁÖÀÔ ÆßÇÁÀÇ ±â¼úÀû Áøº¸
    • °úÁ¦
      • Àç»ý ÁÖÀÔ ÆßÇÁÀÇ Ã¤¿ë Áõ°¡
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀå : Á¦Ç°º°

  • ÈÞ´ëÇü ÁÖÀÔ ÆßÇÁ
  • °æÀå ÁÖÀÔ ÆßÇÁ
  • ¸Å¸³Çü ÁÖÀÔ ÆßÇÁ
  • Àν¶¸° ÁÖÀÔ ÆßÇÁ
  • ȯÀÚ Àڱ⠰ü¸® ÁøÅë ÁÖÀÔ ÆßÇÁ
  • ÁÖ»ç±â ÁÖÀÔ ÆßÇÁ
  • ¿ëÀû½Ä ÁÖÀÔ ÆßÇÁ

Á¦7Àå Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀå : Áúȯ ÀûÀÀÁõº°

  • ÁøÅë ¶Ç´Â ÅëÁõ °ü¸®
  • È­Çпä¹ý
  • ´ç´¢º´
  • ¼ÒÈ­±â ³»°ú
  • Ç÷¾×ÇÐ
  • ¼Ò¾Æ°ú, ½Å»ý¾Æ°ú

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Á¤¸Æ³» ÁÖÀÔ ÆßÇÁ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Adepto Medical
  • ANGEL Electronics
  • B. Braun Melsungen AG
  • Baxter International
  • Becton, Dickinson and Company
  • Boston Scientific corporation
  • Carefusion Corporation
  • CODAN ARGUS AG
  • F. Hoffmann La Roche Ltd.
  • Fresenius SE & Co.
  • Ivenix Inc.
  • J2S Medical
  • Medtronic Plc.
  • Micrel Medical Devices Sa
  • Pfizer Inc.
  • Shenzhen Hawk Medical Instrument Co. Ltd.
  • Smiths Medical Plc.
  • Terumo Corporation
  • Venner Medical
  • ZOLL Medical Corporation
BJH 24.11.22

The Intravenous Infusion Pump Market was valued at USD 4.44 billion in 2023, expected to reach USD 4.85 billion in 2024, and is projected to grow at a CAGR of 9.85%, to USD 8.57 billion by 2030.

Intravenous (IV) infusion pumps are critical medical devices designed to deliver fluids, such as nutrients and medications, directly into a patient's bloodstream in controlled amounts. Their necessity arises from the need for precise administration of fluids, especially in critical care settings, to ensure optimal therapeutic outcomes and patient safety. They are widely used in healthcare facilities including hospitals, outpatient clinics, and home healthcare settings. The end-use scope spans across diverse medical domains, including oncology, gastroenterology, pediatrics, and pain management, where precise fluid administration is crucial. The growing prevalence of chronic diseases, increasing geriatric population, and technological advancements in healthcare devices are key growth factors driving the IV infusion pumps market. The latest potential opportunities in this market lie in the integration of smart technologies such as cloud computing and IoT, which enable enhanced data analytics and remote monitoring capabilities. To seize these opportunities, companies should focus on collaborative innovations with tech firms, expand R&D efforts, and enhance regulatory compliance. However, limitations such as high costs of advanced pumps, stringent regulatory requirements, and risks of technical malfunctions pose significant challenges to market growth. Additionally, the need for trained healthcare professionals to operate these devices and ensure patient safety may impede market expansion. Areas ripe for innovation include developing cost-effective infusion pumps equipped with advanced safety features, improving wireless communication capabilities, and enhancing user interface designs to reduce human error. Research into reducing device size for portability without compromising functionality could also drive market growth. The IV infusion pump market is competitive, characterized by continuous technological advancements and rigorous regulatory frameworks that necessitate constant innovation to meet evolving healthcare standards and demands. Adopting a proactive approach towards technology integration and compliance will be crucial for businesses aiming to achieve sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 4.44 billion
Estimated Year [2024] USD 4.85 billion
Forecast Year [2030] USD 8.57 billion
CAGR (%) 9.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intravenous Infusion Pump Market

The Intravenous Infusion Pump Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of chronic diseases along with geriatric population
    • Rising number of people undergoing surgical procedures
    • Increasing demand for ambulatory infusion pumps
  • Market Restraints
    • Patient safety risk and medication errors to infusion pumps
  • Market Opportunities
    • Growing adoption of specialty infusion pumps
    • Technological advancements in infusion pumps
  • Market Challenges
    • Increasing adoption of refurbished infusion pumps

Porter's Five Forces: A Strategic Tool for Navigating the Intravenous Infusion Pump Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intravenous Infusion Pump Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intravenous Infusion Pump Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intravenous Infusion Pump Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intravenous Infusion Pump Market

A detailed market share analysis in the Intravenous Infusion Pump Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intravenous Infusion Pump Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intravenous Infusion Pump Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intravenous Infusion Pump Market

A strategic analysis of the Intravenous Infusion Pump Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intravenous Infusion Pump Market, highlighting leading vendors and their innovative profiles. These include Adepto Medical, ANGEL Electronics, B. Braun Melsungen AG, Baxter International, Becton, Dickinson and Company, Boston Scientific corporation, Carefusion Corporation, CODAN ARGUS AG, F. Hoffmann La Roche Ltd., Fresenius SE & Co., Ivenix Inc., J2S Medical, Medtronic Plc., Micrel Medical Devices Sa, Pfizer Inc., Shenzhen Hawk Medical Instrument Co. Ltd., Smiths Medical Plc., Terumo Corporation, Venner Medical, and ZOLL Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Intravenous Infusion Pump Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Ambulatory Infusion Pumps, Enteral Infusion Pumps, Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Syringe Infusion Pumps, and Volumetric Infusion Pumps.
  • Based on Disease Indication, market is studied across Analgesia or Pain Management, Chemotherapy, Diabetes, Gastroenterology, Hematology, and Pediatrics & Neonatology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of chronic diseases along with geriatric population
      • 5.1.1.2. Rising number of people undergoing surgical procedures
      • 5.1.1.3. Increasing demand for ambulatory infusion pumps
    • 5.1.2. Restraints
      • 5.1.2.1. Patient safety risk and medication errors to infusion pumps
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing adoption of specialty infusion pumps
      • 5.1.3.2. Technological advancements in infusion pumps
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing adoption of refurbished infusion pumps
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intravenous Infusion Pump Market, by Product

  • 6.1. Introduction
  • 6.2. Ambulatory Infusion Pumps
  • 6.3. Enteral Infusion Pumps
  • 6.4. Implantable Infusion Pumps
  • 6.5. Insulin Infusion Pumps
  • 6.6. Patient-Controlled Analgesia Infusion Pumps
  • 6.7. Syringe Infusion Pumps
  • 6.8. Volumetric Infusion Pumps

7. Intravenous Infusion Pump Market, by Disease Indication

  • 7.1. Introduction
  • 7.2. Analgesia or Pain Management
  • 7.3. Chemotherapy
  • 7.4. Diabetes
  • 7.5. Gastroenterology
  • 7.6. Hematology
  • 7.7. Pediatrics & Neonatology

8. Americas Intravenous Infusion Pump Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Intravenous Infusion Pump Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Intravenous Infusion Pump Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adepto Medical
  • 2. ANGEL Electronics
  • 3. B. Braun Melsungen AG
  • 4. Baxter International
  • 5. Becton, Dickinson and Company
  • 6. Boston Scientific corporation
  • 7. Carefusion Corporation
  • 8. CODAN ARGUS AG
  • 9. F. Hoffmann La Roche Ltd.
  • 10. Fresenius SE & Co.
  • 11. Ivenix Inc.
  • 12. J2S Medical
  • 13. Medtronic Plc.
  • 14. Micrel Medical Devices Sa
  • 15. Pfizer Inc.
  • 16. Shenzhen Hawk Medical Instrument Co. Ltd.
  • 17. Smiths Medical Plc.
  • 18. Terumo Corporation
  • 19. Venner Medical
  • 20. ZOLL Medical Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦